The global medical perfusion technology market is growing at a CAGR of 5.6%

MIAMI, Fla., Oct. 5, 2022 (GLOBE NEWSWIRE) — According to a new research report by Facts and Factors titled “Medical Perfusion Technology Market by Technology (Cryogenic Machine Perfusion and Normothermic Machine Perfusion), Organ Type (Heart, Lung, Kidney, Liver, and Others), Component (Perfusion Pump, Oxygenator, Heart-Lung Machine, Monitoring System, Cannula, & Others), and by Region – Global and Regional Industry Perspectives, Comprehensive Analysis and Forecast 2020-2026” in its research database.

“According to the latest research, global demand Medical perfusion technology market size The 2020 revenue share was $750.15 million and is expected to exceed $905.5 million by 2026, growing at a compound annual growth rate (CAGR) of approximately 5.6% during the forecast period from 2021 to 2026. “

medical perfusion technology market Overview:

Medical perfusion technology is the scientific study of the human anatomy that connects the lungs and adjacent organs. During surgical procedures, these medical perfusion devices often mimic the function of the lungs and heart during surgical procedures, the latter organs having to rest. The key drivers for the growth of the medical perfusion technology market are the increasing prevalence of organ system failure among the elderly and elderly, and the increase in chronic diseases, among others.

The increased features of these devices, such as increased organ preservation measures and extended shelf life of these organs, will further drive sales in the medical perfusion technology market. However, the lack of trained medical professionals and high initial cost will hinder the growth of the medical perfusion technology market to some extent.

Get a free sample PDF of this research report for more insights with table of contents, research methodology and diagrams – https://www.fnfresearch.com/sample/medical-perfusion-technology-market

(A free sample of this report is available upon request; please contact us for more information.)

Our free sample report includes the following:

  • Introduction, overview and in-depth industry analysis are included in the 2021 updated report.
  • COVID-19 Pandemic Outbreak Impact Analysis Included in Packaging
  • About 194+ pages of research reports (including recent research)
  • Detailed chapter-by-chapter guidance upon request
  • Updated regional analysis with graphical representations of size, share, and trends in 2021
  • Include tables and figures have been updated
  • The latest version of the report includes top market players, their business strategies, sales volume and revenue analysis
  • Facts and Factors Research Methods

Market Growth Dynamics

Inorganic partnerships and mergers and acquisitions are frequently employed by major players in the industrial sector in order to sustain themselves in a highly competitive market. The market is flooded with the latest innovations, which are often incorporated in multi-year R&D cycles.

Furthermore, the increase in the number of distributors of medical perfusion technology is expected to trigger intense competition, which will eventually lead to a pricing crisis among competitors. The pace of innovation is often hampered by a lack of product acceptance by global and local organizations.

Purchase a copy of the report with TOC directly@ https://www.fnfresearch.com/buynow/su/medical-perfusion-technology-market

segmentation analyze:

The global medical perfusion technology market can be segmented based on technology, organ type, component, and region.

On the basis of technology, the global medical perfusion technology market can be divided into low temperature machine perfusion and normal temperature machine perfusion. Low temperature machine perfusion will hold the largest market share over the forecast period owing to viable alternatives to refrigeration solutions and improved post-operative downtime conditions.

Based on organ type, the global medical perfusion technology can be subdivided into heart, lung, kidney, liver, etc. During the forecast period, the renal segment will hold the largest market share owing to factors such as increasing renal preservation function in these devices. The cardiac segment will account for the fastest CAGR segment during the forecast period.

The global medical perfusion technology market is segmented as follows:

Analysis in the technical field

  • low temperature machine infusion
  • Normal temperature machine perfusion

Segmental analysis by organ type

  • Heart
  • lung
  • kidney
  • liver
  • other

Segment analysis in components

  • perfusion pump
  • Oxygenator
  • heart lung machine
  • surveillance system
  • casing
  • other

Browse complete “Medical Perfusion Technology Market by Technology (Cryogenic Machine Perfusion and Normothermic Machine Perfusion), Organ Type (Heart, Lung, Kidney, Liver, and Others), Component (Perfusion Pump, Oxygenator, Heart-Lung Machine, Monitoring System, Cannula, & Others), and by Region – Global and Regional Industry Perspectives, Comprehensive Analysis and Forecast 2020-2026” reported on https://www.fnfresearch.com/medical-perfusion-technology-market

Competitive Landscape

The report also provides an in-depth analysis of key competitors in the market and provides information on their competitiveness. The study also identifies and analyzes important business strategies such as mergers and acquisitions (M&A), affiliates, collaborations, and contracts used by these key market players. Among other things, the study looked at each company’s global reach, competitors, service offerings and standards. Some of the key competitors dominating the global medical perfusion technology market include-

  • Paragonix Technology
  • TransMedics Inc.
  • Organic Cow Co., Ltd.
  • Bridge of Life Limited
  • Getinge AB
  • Medtronic
  • LivaNova PLC
  • XENIOS AG.

Key insights from the main study:

  • According to the analysis shared by our research forecasters, the medical perfusion technology market is likely to grow at a CAGR of around 5.6% during the forecast period (2021-2026).
  • In terms of revenue, the medical perfusion technology market size was estimated at USD 750.15 million in 2020 and is expected to reach USD 905.5 million by 2026.
  • On the basis of technology, the cryogenic machine infusion segment is expected to regain the largest market value over the forecast period, in terms of revenue and sales.
  • On the basis of organ type, the segment related to kidney transplantation will hold the largest market share during the forecast period.
  • Regionally, North America will recapture some of the most revenue-generating markets.

main products:

  • Market Size and Revenue Forecast | 2021−2026
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints and Investment Opportunities
  • Market Segmentation – Detailed Analysis by Technology, Organ Type, Component and Region
  • Competitive Landscape – Top Key Vendors and Other Notable Vendors

Customize this report according to your requirements – https://www.fnfresearch.com/customization/medical-perfusion-technology-market

(We will tailor your report to your specific research requirements. Please consult our sales team to customize your report.)

Regional Analysis:

During the forecast period, North America is expected to have the largest market share in terms of global revenue contribution. The widening gap between supply and demand of organs will drive the growth of the medical perfusion technology market in the region. Certain factors related to the growth of the market can be further attributed to expanding government funding, increasing awareness of medical perfusion, and increasing R&D activities in the industry.

By region

  • North America
    • us
    • Canada
    • Rest of North America
  • Europe
    • France
    • U.K.
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Report Scope

report properties detail
Market size in 2020 $750.15 million
Estimated market size in 2026 $905.5 million
compound annual growth rate 5.6% CAGR
base year 2020
forecast year 2021-2026
major market players Paragonix Technologies, TransMedics Inc., OrganOx Limited, Bridge to Life Ltd., Getinge AB, Medtronic, LivaNova PLC and XENIOS AG. etc.
Important section By Technology, Organ Type, Composition, and Region
Main areas covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
purchase options Request custom purchase options to meet your research needs.

Browse other related research reports from Facts & Factors:

Regarding facts and factors:

Facts & Factors is a leading market research agency that provides industry expertise and thoughtful consulting services for clients’ business development. The reports and services provided by Facts and Factors are used by the world’s leading academic institutions, start-ups and companies to measure and understand the changing international and regional business context.

contact us:

Facts and Factors

U.S: +1 347 690-0211 | U.K: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999

e-mail: sales@fnfresearch.com | website: https://www.fnfresearch.com

follow us – LinkedIn | Twitter | Facebook

Source link